Feline hyperthyroidism is the most common endocrine disease of older cats, causing significant welfare compromise that responds very well to multiple effective treatment options.
Feline hyperthyroidism welfare reflects the excellent outcomes achievable when a common chronic disease is effectively treated. The untreated condition causes significant welfare compromise: the metabolic hyperactivity from excess thyroid hormone results in muscle wasting, cardiovascular strain, hypertension, and progressive organ damage. Affected cats show hyperactivity, restlessness, and altered behaviour that may be distressing for both animal and owner. The excellent treatment options available mean that hyperthyroidism diagnosed in time can be effectively managed or cured, with dramatic welfare improvement. Radioactive iodine treatment, the gold standard, eliminates the thyroid tumour with a single treatment, requiring only a brief period of isolation due to radioactivity - after which the cat returns to normal thyroid function with no further medication needed. Daily medication provides effective control but requires owner compliance and may cause side effects in some cats. The welfare concern in hyperthyroidism is primarily diagnostic delay: the gradual onset of signs means owners frequently attribute changes to normal ageing rather than recognising a treatable disease, allowing welfare compromise to accumulate over months or years before diagnosis.